Skip to main content
. Author manuscript; available in PMC: 2025 Feb 7.
Published in final edited form as: Circ Genom Precis Med. 2024 Feb 7;17(1):e004192. doi: 10.1161/CIRCGEN.123.004192

Table 2.

Association with incident and prevalent diabetes in replication cohorts (FHS and WHI). *Sex adjustment was not performed in WHI (given study sample was women only), and race adjustment was not performed in FHS.

Prevalent diabetes
Framingham Heart Study Women’s Health Initiative
Proteomic score Adjustments* Odds Ratio P Odds Ratio P
Pro-inflammatory proteotype score Age + Sex + Race 1.38 (1.10-1.72) 0.005 1.24 (1.08-1.43) 0.003
Age + Sex + Race + BMI 1.07 (0.81-1.41) 0.64 1.02 (0.84-1.23) 0.87
Muscularity proteotype score Age + Sex + Race 1.33 (0.98-1.79) 0.06 0.90 (0.79-1.03) 0.12
Age + Sex + Race + BMI 1.34 (0.99-1.83) 0.06 0.91 (0.80-1.05) 0.2
Diabetes (Cox) score Age + Sex + Race 1.87 (1.49-2.36) <0.0001 1.27 (1.10-1.46) 0.0008
Age + Sex + Race + BMI 1.70 (1.32-2.18) <0.0001 1.14 (0.97-1.34) 0.11
 
Incident diabetes
Framingham Heart Study Women’s Health Initiative
Proteomic score Adjustments* Odds Ratio P Hazard Ratio P
Pro-inflammatory proteotype score Age + Sex + Race 1.98 (1.28-3.06) 0.002 1.21 (1.01-1.45) 0.04
Age + Sex + Race + BMI + Fasting glucose 1.39 (0.77-2.51) 0.27 1.04 (0.81-1.34) 0.75
Muscularity proteotype score Age + Sex + Race 1.38 (0.80-2.37) 0.25 1.06 (0.88-1.27) 0.56
Age + Sex + Race + BMI + Fasting glucose 1.37 (0.77-2.46) 0.29 1.00 (0.82-1.20) 0.97
Diabetes (Cox) score Age + Sex + Race 1.91 (1.28-2.85) 0.002 1.26 (1.05-1.50) 0.01
Age + Sex + Race + BMI + Fasting glucose 1.24 (0.77-2.01) 0.37 1.06 (0.86-1.32) 0.57